Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study

• Yi-Chun Yeh,

  Affiliations Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, Center for Comparative Effectiveness Research, National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan

  ⨯
• Chun-Jen Liu,

  Affiliations Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan, Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Raymond Nienchen Kuo,

  Affiliation Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan

  ⨯
• Chiu-Ling Lai,

  Affiliation Department of Health Industry Management, School of Healthcare Management, Kainan University, Taoyuan, Taiwan

  ⨯
• Wen-Yi Shau,

  Affiliations Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, Medical Affairs Division, Pfizer Limited, New Taipei, Taiwan

  ⨯
• Pei-Jer Chen ,

  * E-mail: peijerchen@ntu.edu.tw (P-JC); mslai@ntu.edu.tw (M-SL)

  Affiliations Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan, Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Mei-Shu Lai

  * E-mail: peijerchen@ntu.edu.tw (P-JC); mslai@ntu.edu.tw (M-SL)

  Affiliations Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan, Center for Comparative Effectiveness Research, National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan

  ⨯